Boehringer Ingelheim Venture Fund

What they invest in

[name locked] is a seasoned investor with a focus on digital healthcare investments in Europe and Israel. His investment thesis revolves around supporting innovative technologies in areas such as immuno-tolerization, hearing loss treatments, cancer immunotherapies, molecular biology, behavioral economics, and medical data analytics. [name locked]'s previous investments include companies like Abalos Therapeutics, Acousia Therapeutics, Actym Therapeutics, and eTheRNA immunotherapies. His track record includes roles at major pharmaceutical companies and academic research in myocardial perfusion and stress echocardiography. In terms of investment check size, [name locked] has been involved in funding rounds like the €4.1 million raised by C-mo Medical Solutions. Known for his detailed approach and collaborations, [name locked]'s partnership style focuses on enabling precision medicine concepts with biomarker data.

Who works there

9 people on file: 9 with an email address, 9 with a phone number, 8 with a professional profile. Names and details are behind a free account.

No card. Each contact is charged once and stays yours.